These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6189822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE, Petkovich PM, Rosenthal EE, Heersche JN.
    Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity.
    Murray E, Provvedini D, Curran D, Catherwood B, Sussman H, Manolagas S.
    J Bone Miner Res; 1987 Jun; 2(3):231-8. PubMed ID: 2843003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells.
    Mahonen A, Pirskanen A, Keinänen R, Mäenpää PH.
    Biochim Biophys Acta; 1990 Jan 30; 1048(1):30-7. PubMed ID: 2153413
    [Abstract] [Full Text] [Related]

  • 8. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
    Kiriyama T, Okamoto S, Ejima E, Kurihara N, Hakeda Y, Ito N, Izumi M, Kumegawa M, Nagataki S.
    Endocrinology; 1991 Jan 30; 128(1):81-6. PubMed ID: 1846118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S, Donaldson CA, Haussler MR.
    Cancer Res; 1984 May 30; 44(5):2103-9. PubMed ID: 6324995
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
    Valaja T, Mahonen A, Pirskanen A, Mäenpää PH.
    Biochem Biophys Res Commun; 1990 Jun 15; 169(2):629-35. PubMed ID: 2162670
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH, Price PA, Deftos JL, Manolagas SC.
    Endocrinology; 1986 Apr 15; 118(4):1340-6. PubMed ID: 3485045
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.